跳至主要内容
临床试验/NCT05709912
NCT05709912进行中(未招募)不适用

Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Caregivers of Patients Receiving Hematopoietic Cell Transplantation (HCT)

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120
试验地点
2
主要终点
Caregiver quality of life (QOL) as measured by the Caregiver Oncology Quality of Life (CARGOQOL) questionnaire

研究概览

简要总结

The goal of this research study is to determine whether a self-administered, psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT).

详细描述

This is a randomized clinical trial to determine whether a psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT). The CARE app was developed with the goal of addressing the needs of caregivers of HCT recipients.

Participants will be randomized into one of two study groups: CARE app plus Usual Care versus Usual Care.

Participation in this study is expected to last up to 100 days after HCT.

It is expected that about 120 people will take part in this research study.

The Leukemia and Lymphoma Society is supporting this research by providing funding.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult caregivers (>18 years) who is a relative or friend who live with the patient or is a designated caregiver as indicated during the transplant process.
  • Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer
  • Ability to comprehend and speak English as the CARE app is only available in English

排除标准

  • Caregivers of patients undergoing HCT for benign hematologic conditions
  • Caregivers with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures

结局指标

主要结局

Caregiver quality of life (QOL) as measured by the Caregiver Oncology Quality of Life (CARGOQOL) questionnaire

时间窗: up to 60 days post-HCT

Compare caregiver QOL as measured by the CARGOQOL between the two study groups. The CARGOQOL ranges from 0-100 with higher scores indicating better QOL

次要结局

  • Depression symptoms as measured by the Hospital Anxiety and Depression Scale (HADS-Depression)(Up to 100 days post HCT)
  • Caregiver quality of life (QOL) as measured by the Caregiver Oncology Quality of Life (CARGOQOL) questionnaire(up to 100 days post HCT)
  • Anxiety symptoms as measured by the Hospital Anxiety and Depression scale (HADS-Anxiety)(Up to 100 days post HCT)
  • Caregiving burden as measured by the Caregiver Reaction Assessment (CRA)(Up to 100 days post HCT)
  • Post-traumatic stress symptoms (PTSD) as measured by the PTSD Checklist(Up to 100 days post HCT)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

El-Jawahri, Areej,M.D.

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验